現代の毒理学における複雑さ: 短期的な生体内研究におけるオミクスの役割
Constance A Mitchell1, Leah Wehmas2, David Rouquie3
1Health and Environmental Sciences Institute, Washington, DC, USA.
まとめ
毒理学は,短期的な研究から得られるオミックスデータを用いて,予測的で人間に関連したリスク評価を進めている. これらの次世代リスク評価 (NGRA) アプローチは,よりよい危険性識別のために分子データを統合することによって,動物実験を減らすことができます.
科学分野:
- 毒性学とリスク評価
- 分子毒理学
- 規制科学
背景:
- 毒理学分野は予測的でメカニズムに基づいたアプローチに移行しています
- 短期 in vivo 研究におけるオミックスのエンドポイントは,早期の分子毒性指標を提供する.
- これらの方法は,より迅速で人間に関連したリスク評価のために,従来の動物実験への依存を減らすことを目的としています.
研究 の 目的:
- 次世代リスク評価 (NGRA) の規制ニーズとオミクスの技術的進歩を一致させるための洞察を要約する.
- 様々な製品分野におけるNGRAの枠組みにおけるオミックスデータの重要性を強調する.
- 新しいアプローチの方法論 (NAM) の橋渡しとして,短期的な機械的動物研究の役割について議論する.
主な方法:
- 短期的な in vivo 研究から得られるオミクスデータ (例えば,トランスクリプトミクス,プロテオミクス) を利用する.
- 分子出発点 (mPOD) と他の生物学的に固定されたメトリックを導出します.
- オミックス対応のNGRAに関する毒理学学会 (SOT) のセッションの洞察を要約します.
主要な成果:
- オミックスのデータ生成,分析,解釈は著しく成熟しました.
- オミックスのデータから得られた生物学的アンカーメトリックは,効能のランキングと危険性の識別を告げる.
- NGRAの枠組みは,各セクターの特定の規制要件と曝露状況に合わせる必要があります.
結論:
- オミックス対応の危険性プロファイルは,NGRAをサポートする大きな可能性を秘めています.
- バイオインフォマティクスの標準化,アピカルエンドポイントに対する検証,そしてトレーニングの拡大は重要な課題です.
- 協力的な科学と柔軟な規制の枠組みは,毒理学におけるオミックスの完全な可能性を実現するために不可欠です.
さらに関連する動画
関連する概念動画
Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Genomics
37.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.4K
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K


